Do Selective Cyclo-Oxygenase-2 Inhibitors Have a Future? Bernard Bannwarth Current Opinion 20 November 2012 Pages: 183 - 189
Extrapyramidal Symptoms with Atypical Antipsychotics Joseph M. Pierre Review Article 20 November 2012 Pages: 191 - 208
Protease Inhibitor-Induced Diabetic Complications Lillian F. LienMark N. Feinglos Review Article 20 November 2012 Pages: 209 - 226
Tolerability of Paracetamol Garry G. GrahamKieran F. ScottRichard O. Day Review Article 20 November 2012 Pages: 227 - 240
Tibolone and Endometrial Cancer Corinne S. de VriesSusan E. BromleyRichard D.T. Farmer Original Research Article 20 November 2012 Pages: 241 - 249
Identification of Priorities for Medication Safety in Neonatal Intensive Care Desireé L. KunacDavid M. Reith Original Research Article 20 November 2012 Pages: 251 - 261
Prevalence of Potentially Severe Drug-Drug Interactions in Ambulatory Patients with Dyslipidaemia Receiving HMG-CoA Reductase Inhibitor Therapy Alexandra E. Rätz BravoLydia TchambazStephan Krähenbühl Original Research Article 20 November 2012 Pages: 263 - 275